CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 10 enrolled
Drug / intervention
PG-760564 +1 moredrug
Likely dose
PG-760564 200 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00791817
NCT00791817Phase 1Completed
CompareCT.gov

An Open-label, Single Dose, Randomized, Crossover Study to Evaluate Potential Food Effects

Procter and Gamble·interventional·Posted Nov 17, 2008·Updated Sep 7, 2011

In Brief

A Phase 1 clinical trial evaluating PG-760564 for Healthy. Completed, enrolled 10 participants across 1 site.

Detailed Summary

Half the group will be given a high fat diet and the other half will fast. They will then be crossed over.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--

Timeline

Phase 1CompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 17, 2008
Enrollment StartAug 1, 2005
Primary CompletionJan 1, 2006
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 17.6 years ago

Interventions

PG-760564drug

200 mg capsule, single dose,fasted when dosed, duration is 4 days

PG-760564drug

200 mg capsule, single dose,high fat diet when dosed, duration is 4 days